Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Translational Validation Trial-B
DRKS00004186Phase 2Completed
- Sponsor
- Universitätsmedizin Göttingen
- Start
- Oct 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil, oxaliplatin and folinic acid in rectal cancer, sponsored by Universitätsmedizin Göttingen. Started Oct 2012; status: completed.
02
Drugs
fluorouraciloxaliplatinfolinic acid
03
Conditions
rectal cancer
Beyond the preview
Go deeper on DRKS00004186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004186.